Health and Healthcare
Health and Healthcare Articles
Cassava Sciences reported good results from a mid-stage study of its sumifilam treatment for Alzheimer's disease. Shares soared on the news.
Published:
Telemedicine platform provider GoodRx intends to price more than 34 million shares for an initial public offering valued up to more than $1 billion.
Published:
Immunomedics shares more than doubled on Monday after the firm announced that it would be acquired by Gilead Sciences in one of the biggest deals to go down in the health care sector this year.
Published:
Temperatures have set records around the world recently, and the warmest places are routinely over 110 degrees F during the day. Extreme heat, over 120 degrees, is rare, but in this city in...
Published:
The August 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
One of the most widely respected COVID-19 case models forecasts 2.8 million deaths by the end of the year. That means a sharp acceleration in deaths over the next three and a half months.
Published:
After Satsuma Pharmaceuticals reported disappointing late-stage results from its migraine treatment, and its shares were absolutely crushed Thursday morning.
Published:
The FDA has approved Innoviva's treatment of asthma and for patients with chronic obstructive pulmonary disease, the company announced, giving shares a boost early Thursday.
Published:
Practically any biotech company attempting almost anything COVID-19 related has seen massive gains. However, there is likely more to come for the rest of the year and into next year. These five...
Published:
iBio has announced that it has selected a vaccine to advance for the prevention of infection by the coronavirus that causes COVID-19.
Published:
There is no cure for mesothelioma, but some companies are looking for better ways to treat the disease.
Published:
Intra-Cellular Therapies was one of the biggest winners on Wednesday after the company announced positive results from its late-stage clinical trial in patients with bipolar disorder.
Published:
A key update from the FDA on its treatment for relapsed/refractory multiple myeloma boosted Precision BioSciences shares early on Wednesday.
Published:
Co-Diagnostics announced Tuesday that it has entered into an agreement with Arches Research to expand Arches' COVID-19 testing services using Co-Diagnostics’ test kit.
Published:
The race for finding the COVID-19 vaccine is in full swing, and it has just seen one team move ahead of the others. Before getting into an actual prediction basis for knowing which vaccine (or...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.